… (generic Adcirca), a pulmonary hypertension medication, was acquired by PBMs for … of NADAC. Drugs for multiple sclerosis accounted for 25%, while treatments for transplant-related … critical medications, the role of PBMs and their impact on drug pricing …

… for diagnosis and treatment strategies.1 The … were both on immunomodulatory treatments. To be included, … . Thalamic volume differentiates multiple sclerosis from neuromyelitis optica spectrum … study. Front Neurol Multiple Sclerosis and Neuroimmunology. 2025 …

… of MRI lesions indicative of multiple sclerosis (MS) in patients who … 2024 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, September … insights on how clinicians approach treatment decisions in patients with low …

… both instances would void the treatment. But I have true hope … challenges, having been diagnosed with Multiple Sclerosis a few years ago. … than our illnesses. “This treatment will allow me to reclaim … your right to the best treatment, you can fight to …

The Scottish Medicines Consortium has approved relugolix combination therapy for endometriosis, risankizumab for ulcerative colitis, ublituximab for relapsing-remitting multiple sclerosis (MS), and ciclosporin eye drops for dry eye disease. by Dawn Liz …

… predicting the progression of multiple sclerosis (MS) to secondary … on low-efficacy treatment. These results were … Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) … Conversion to Secondary Progressive Multiple Sclerosis. Presented at: 2024 …

… to marijuana) and the drug became associated with poor … treatment for some chronic conditions such as cancer pain and multiple sclerosis … are using other prescription drugs. Several different species of … also known as diamorphine). Drug firm Bayer thought it …

… Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) … of prior disease-modifying treatments. Additional findings, … evidence supporting early treatment benefits. Krüger, … of high-efficacy treatment in Multiple Sclerosis. Presented at: …

… largest drug middlemen "inflated the costs of numerous life-saving medications … 30-day supply of the medication on commercial claims," the … marking up lifesaving drugs like cancer, HIV, and multiple sclerosis treatments by thousands of …

Treatments and medications for serious health conditions can … marked up some specialty generic drugs dispensed at their affiliated pharmacies … fumarate (Tecfidera), a drug used to treat multiple sclerosis, had an acquisition cost …